BIOMES

Wildau, Germany Founded: 2017 • Age: 9 yrs
Gut health diagnostics via home-based genetic testing are provided.
Annual revenue - Latest available
Total funding $2.2M 1 rounds
Employees 45 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About BIOMES

BIOMES is a company based in Wildau (Germany) founded in 2017 by Paul Hammer, Christin Gunther, Jonas Dierenbach, Andrej Wackerow, and Carsten Krumbiegel. BIOMES has raised $2.17 million across 1 funding round from investors including Yabeo. The company has 45 employees as of December 31, 2019.

  • Headquarter Wildau, Germany
  • Employees 45 as on 31 Dec, 2019
  • Founders Paul Hammer, Christin Gunther, Jonas Dierenbach, Andrej Wackerow, Carsten Krumbiegel
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.17 M (USD)

    in 1 rounds

  • Latest Funding Round
    $2.17 M (USD), Seed

    Feb 13, 2020

  • Investors
  • Employee Count
    45

    as on Dec 31, 2019

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of BIOMES

Headcount 50-200
Employee Profiles 1
Employee Profiles
People
Ivan Francisco Rodriguez Martinez
CEO Latam

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of BIOMES

BIOMES has successfully raised a total of $2.17M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.17 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $2.2M
  • First Round

    (13 Feb 2020)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2020 Amount Seed - BIOMES Valuation Yabeo

Investors in BIOMES

BIOMES has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Yabeo.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage tech investments in Germany are targeted by Yabeo.
Founded Year Domain Location

Investments & Acquisitions by BIOMES

Investments

Financial Statements - BIOMES

Biomes Comparisons

+
Add Comparison
Available on Premium

Competitors of BIOMES

Latest news on Biomes

Frequently Asked Questions about BIOMES

BIOMES was founded in 2017 and raised its 1st funding round 3 years after it was founded.

BIOMES is headquartered in Wildau, Germany. It is registered at Wildau, Brandenburg, Germany.

Paul Hammer is the current CEO of BIOMES. They have also founded this company.

BIOMES is a funded company, having raised a total of $2.17M across 1 funding round to date. The company's 1st funding round was a Seed of $2.17M, raised on Feb 13, 2020.

As of Dec 31, 2019, the latest employee count at BIOMES is 45.

BIOMES was founded in 2017 in Wildau, Germany, within the biotech sector focused on genetic testing. Home-based self-tests for intestinal flora are offered, utilizing next-generation sequencing technologies. Stool samples are submitted by users for laboratory analysis, yielding a microbiota profile that details identified bacteria, flora balance, unwanted pathogens, immune indicators, and inflammatory markers. Operations center on personalized gut health insights.

BIOMES has 1 investor. Key investors include Yabeo.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available